Admission Date:  [**2104-1-20**]       Discharge Date:  [**2104-2-19**]  Date of Birth:   [**2104-1-20**]       Sex:  F  Service:  Neonatology  HISTORY:  Baby Girl [**Known lastname 52570**] #1 is the former 1175 gram 32-5/7 EGA female [**Known lastname **] by spontaneous vaginal delivery to a 22-year-old G1 P2.
Mother was treated with magnesium sulfate, betamethasone, and ampicillin.
Received blow-by O2.
Has baseline respiratory rate in the 40s to 60s.
She did not require methylxanthine treatment.
She is currently free of apnea, bradycardia, and desaturations for greater than five days.
She did not require pressor support.
Fluids, electrolytes, and nutrition:  Birth weight 1175 less than 10th percentile, discharge weight [**2019**] less than 10th percentile, length 37 cm less than 10th percentile.
Infant was initially started on peripheral IV fluid of D10W at 80 cc/kg.
Enteral feedings were introduced once her transitory respiratory distress resolved on day of life one.
She did receive parenteral nutrition via peripheral IV and had enteral feedings started in advance without issues.
She advanced to breast milk 30 calories with ProMod at 150 cc/kg/day.
She is also receiving supplemental ferrous sulfate 25 mg/ml 0.15 mL which equals 2 mg/kg/day.
Responded to single phototherapy.
Hematology:  Baby did not require any blood products during this admission.
She was started on 48 hours of ampicillin and gentamicin.
She was also treated for diaper rash that looked monilial with nystatin powder to the diaper area that was discontinued on [**2-3**].
She then had a diaper rash that responded to Criticade for protection.
CARE RECOMMENDATIONS:  Continue NeoSure 26 calories/ounce adlib.
IMMUNIZATIONS RECEIVED:  No immunizations until date parents have chosen to have both girls receive hepatitis vaccine at pediatrician's visit as [**Known lastname 8254**] has been less than [**2099**] grams.
IMMUNIZATIONS RECOMMENDED:  Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1) [**Month (only) **] at less than 32 weeks, 2) [**Month (only) **] between 32 and 35 weeks with two of three of the following: daycare during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities, or with school-age siblings, or 3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other caregivers should be considered for immunization against influenza to protect the infant.
[**Hospital1 **] [**First Name (Titles) **] [**Last Name (Titles) **] Intervention Program [**Telephone/Fax (1) 50120**].
